Two GDP Non-Compliance Reports published in March
Recommendation

22 October 2026
Good Distribution Practice of Active Substances for Human and Veterinary Medicinal Products
Two new GDP Non-Compliance Reports have recently been published in the EudraGMDP database, both following the identification of serious violations of Good Distribution Practice (GDP) requirements.
The first report, dated 20 March 2025 (report number: NCCENTROM/2025/001, inspection date: 11 December 2024), was issued by the Competent Authority of Cyprus (Pharmaceutical Services, Ministry of Health). It states that the wholesale distributor had supplied medicinal products to unauthorized entities, which is a clear violation of GDP standards.
The second report, dated 26 March 2025 (report number: 482076-103624037, inspection date: 04 December 2024), was published by the Austrian Federal Office for Safety in Health Care. Here, the authority notes in general terms that the distributor does not comply with the EU GDP Guideline, without specifying further details.
In both cases, the respective Wholesale Distribution Authorisation (WDA) was withdrawn.
Source: EudraGMDP Database *
* To find the respective report, please click on "Non-Compliance Reports" in the menu on the left-hand side and select in "From Date / To Date" the month the inspection took place. After clicking on "Search" the results list will be displayed, from which you can choose the report with the number mentioned above.
Related GMP News
30.09.2026European GDP Association Developments May through August 2026
30.09.2026Warehouse Temperature Excursions: What Does the FDA Expect?
30.09.2026Version 4.0 of the Swissmedic Document on Notifications of Changes Published
30.09.2026USA: Court Stops Warehouse Activities Following Persistent Insanitary Warehouse Conditions
30.09.2026GDP Non-Compliance Report: CAPA Measures must not only be Promised but also Implemented
10.09.2026Reminder: Submit your Presentation Proposal for the GDP Forum 2027 by 30 September


